MITF and melanoma: Because ATRA treatment of melanoma cells in culture induced differentiation and apoptosis in context with increased expression of MITF [87], ATRA may provide a combinational therapeutic tool against certain melanomas—to tackle both, melanoma SC and therapy resistance, via key regulator MITF and related gene expression.